42.59
-0.2534(-0.59%)
Currency In USD
Address
United States of America
Phone
N/A
Website
N/A
Sector
Financial Services
Industry
Asset Management - Global
Employees
N/A
First IPO Date
April 10, 2019
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.